Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

7.92

-0.42 (-5.04%)

At close: Dec 5, 2025, 4:00 PM EST

8.25

+0.33 (4.17%)

After-hours: Dec 5, 2025, 7:35 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
Medicines for Childhood and Adult Diseases with Equal Intensity	131.16M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
United States	131.16M